FDA.MI(FDA.MI)
FDA.MI
No analyst ratings available
No analyst price targets available for FDA.MI
Analyst coverage may not be available for this symbol
Earnings surprise history unavailable.
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $51M | $51M | $49M | $26M | $30M |
| Low | $51M | $51M | $49M | $26M | $30M |
| High | $51M | $51M | $49M | $26M | $30M |
| EBITDA Avg | $-2M | $-2M | $-2M | $-829,635 | $-957,271 |
| Low | $-2M | $-2M | $-2M | $-829,635 | $-957,271 |
| High | $-2M | $-2M | $-2M | $-829,635 | $-957,271 |
| EBIT Avg | $-5M | $-5M | $-4M | $-2M | $-3M |
| Low | $-5M | $-5M | $-4M | $-2M | $-3M |
| High | $-5M | $-5M | $-4M | $-2M | $-3M |
| Net Income Avg | $-4.85B | $-6.93B | $-13.16B | $-33.94B | $-11.43B |
| Low | $-4.85B | $-6.93B | $-13.16B | $-33.94B | $-11.43B |
| High | $-4.85B | $-6.93B | $-13.16B | $-33.94B | $-11.43B |
| EPS Avg | $-14.00 | $-20.00 | $-38.00 | $-98.00 | $-33.00 |
| Low | $-14.00 | $-20.00 | $-38.00 | $-98.00 | $-33.00 |
| High | $-14.00 | $-20.00 | $-38.00 | $-98.00 | $-33.00 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |